biotranslation
biotranslation
  • Home
  • About us
  • Science - Foundations
  • Team
  • Collaborations
  • Pipeline
  • Publications
  • News
  • Contact

PIPeline

About CHB-001 Drug:

  • Promising drug for oncology indications.
  • Mechanism of Action tested in 25 types of different Cancers (Preclinical) combined with several compassionate uses (Clinical).
  • Phase 1 clinical trials have shown it to be safe and well tolerated, even at high doses. 
  • Ready for Phase 2 clinical trials.
  • Exclusively licensed to Biotranslation.

Copyright © 2025 Biotranslation - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept